Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Zynerba Pharma CS (ZYNE)

18.59 -0.11 (-0.59%)

7/24/2017  4:00pm

Open:

18.83

Pre. Close:

18.70

High:

18.83

Low:

18.31

Volume:

367,647

Market Cap:

246.30M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

19.19 - 19.44

19.44 - 20.32

Low:

17.36 - 17.49

17.49 - 17.94

Close:

18.2 - 18.51

18.51 - 19.59

Technical analysis  (as of: 2017-07-24 4:50:52 PM)

Overall:

      

Stoxline posted a SELL today, upgraded from strong sell. But this stock still is very strong for short side. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 24.21     One year: 28.28

Support:

Support1: 18.07    Support2: 16.42

Resistance:

Resistance1: 20.73    Resistance2: 24.21

Pivot:

18.38

Moving Averages:

MA(5): 18.87     MA(20): 18.36

MA(100): 19.73     MA(250): 16.37

MACD:

MACD(12,26): 0.15     Signal(12,26,9): 0.06

%K %D:

%K(14,3): 63.54     %D(3): 67.07

RSI:

RSI(14): 50.89

52-Week:

High: 25.95  Low: 7.02  Change(%): 155.4

Average Vol(K):

3-Month: 39970  10-Days 41938

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
ZYNE has closed below upper band by 43.2%. Bollinger Bands are 22% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 22 Jun 2017 18:45:00 GMT
Cantor Fitzgerald Weighs in on Zynerba Pharmaceuticals, Inc.'s FY2018 Earnings ...

Thu, 19 Jan 2017 16:48:29 GMT
Why Zynerba Pharmaceuticals Inc. Is Tanking Today

Mon, 24 Jul 2017 22:52:30 GMT
Analysts See $-0.60 EPS for Zynerba Pharmaceuticals Inc (ZYNE)

Mon, 27 Mar 2017 18:06:25 GMT
Zynerba Pharmaceuticals' (ZYNE) CEO Armando Anido on Q4 2016 Results ...

Thu, 06 Apr 2017 17:03:45 GMT
Best Stocks for 2017: Zynerba Pharmaceuticals Inc (ZYNE) Stock Dominates in Q1

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

13.25

Shares Float (M)

9.77

% Held by Insiders

% Held by Institutions

Shares Short (K)

1750

Shares Short Prior Month (K)

2800

Stock Financials

EPS

-2.670

EPS Est. Current Year

-2.430

EPS Est. Next Year

-2.730

EPS Est. Next Quarter

-0.600

Forward EPS

-2.730

Book Value (p.s.)

5.880

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-26.9

Return on Equity (ttm)

-46.3

Qtrly Rev. Growth

Gross Profit (p.s.)

0.001

Sales Per Share

EBITDA (p.s.)

-2.007

Qtrly Earnings Growth

Operating Cash Flow (M)

-23.41

Levered Free Cash Flow (M)

-13.17

FoxReading.com

Valuation

P/E

-6.96

P/E Growth Ratio

-0.01

P/BV

3.16

P/S

P/CF

-10.52

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.